Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Clinical research of soothing the liver regulating qi and xiaoying method on chronic early hashimoto thyroiditis
Hits 1558  Download times 2037  Received:August 26, 2011  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2012.01.09
Key Words   chronic early Hashimoto thyroiditis;the method of soothing the liver,regulating qi and xiaoying;clinical research
Author NameAffiliation
WU Xiao-qing Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
ZHANG You-tao Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
HAO Li-peng Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
QIN Si-guan Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
YANG Qi-juan Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
GUAN Wen-wen Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
SHI Chao Endocrinology Department of Huangdao District TCM Hospital, QingDao 266500, China 
Abstract
    [Objective] To evaluate the clinical curative effect of the method of soothing the liver,regulating qi and xiaoying(SLRQXYM)on chronic early hashimoto thyroiditis.[Methods] The 60 patients with chronic early hashimoto thyroiditis were randomly divided into SLRLXYM-treated group(n=30)and control group(n=30).The patients of the SLRLXYM-treated group received treatment of SLRLXYM combined with levothyroxine while the others in the control group received treatment of levothyroxine and prednisone for 12 weeks.The serum levels of thyroid hormones and the titres of serum antithyroglobulin antibody(anti-TG Ab) and antithyroid microsomal antibody(anti-TM Ab)were all examined before and after treatment.The total response rates of the two groups were evaluated after treatment of 12 weeks.[Results] The total effective rate of the SLRQXYM-treated group was 93.3%,while that of the control group had no obvious changes.There was significant difference between SLRQXYM-treated group and control group.[Conclusion] The SLRLXYM can shrink and soften the enlarged thyroid gland and thyroid nodules,improve the immune function of human body,alleviate thyroid autoimmune response,has good clinical effect.

You are the 2318527 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.